Anzeige
Mehr »
Login
Freitag, 24.01.2025 Börsentäglich über 12.000 News von 683 internationalen Medien
Hinter dem nuklearen Ansturm im Silicon Valley: Eine strategische Chance entsteht
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A2JNLR | ISIN: MT0001390104 | Ticker-Symbol:
Branche
Dienstleistungen
Aktienmarkt
Sonstige
1-Jahres-Chart
RAKETECH GROUP HOLDING PLC Chart 1 Jahr
5-Tage-Chart
RAKETECH GROUP HOLDING PLC 5-Tage-Chart
ACCESS Newswire
281 Leser
Artikel bewerten:
(1)

Raketech Presents a Trading Update for the First Quarter 2024 and Revised Full-Year 2024 Guidance

Finanznachrichten News

TRIQ I-IMSIDA IL-GZIRA, MALTA / ACCESSWIRE / May 1, 2024 / Raketech (STO:RAKE) Raketech Group Holding Plc (NASDAQ:RAKE) today issued preliminary results for the first quarter 2024 and revised its guidance for the full year 2024.

  • Revenues for the first quarter of 2024 are expected to amount to EUR 19 million (EUR 16 million)
  • EBITDA in the first quarter of 2024, adjusted for costs related to re-structuring, is expected to amount to EUR 5.1 million (EUR 6.1 million)
  • Reported EBITDA in the first quarter of 2024 is expected to amount to EUR 4.3 million (EUR 6.1 million)

The company has decided to revise its full-year guidance:

  • Current trading, including April, implies an adjusted EBITDA of around EUR 20 million for the full year, compared to the previous guidance of an EBITDA of EUR 24-26 million
  • Free cash flow before earnouts for the full year is estimated to come in just below adjusted EBITDA

During the quarter, Google initiated an extensive Core update. The update was finalized towards the end of April, and we can, to date, conclude a net negative impact related to the Casumba assets, leading us to revise our previously communicated full-year guidance for 2024. The Casumba team is intact, with the original founders onboard, dedicated to continuing to run and oversee the strategy for these products.

Our Swedish assets had a softer first quarter compared to the corresponding quarter of last year, and somewhat impacted by seasonality compared to the previous quarter, but with a stable performance. Our other in-house assets showed good performance, with a positive uplift for our sports products.

Sub-affiliation decreased in revenues compared to the fourth quarter of last year, but EBITDA-contribution was strong, with an increased margin during the quarter and a continued good appetite from our partners.

Our smallest business area, Betting tips and subscription, decreased slightly compared to the previous quarter, coming out from the US sport high season. As previously communicated, we are reviewing our strategy for this area, including digitization of the tipster business.

During the quarter, we implemented efficiency measures following a review of our operating model, to ensure execution power with a better focus on prioritized products and markets and to optimize cash flow.

Raketech's full interim report for the first quarter of 2024 will be published as planned on May 15, 2024.

For more information, please contact:

investor@raketech.com

About Raketech Group

Raketech is a leading online affiliate and content marketing company, with expertise in delivering comparison services for sports and gaming, online guides, communities, and social media products. Raketech guides sports and gaming enthusiasts to the best possible services, while also delivering high-quality traffic and leads to its partners. Raketech grows both organically and via acquisitions and operates its business in accordance with a clear framework for responsible affiliate marketing services. The company's shares are listed in Nasdaq First North Premier Growth Market with ticker RAKE. Carnegie Investment Bank AB (publ) is the company's Certified Adviser. For more information, visit www.raketech.com.

This information is information that Raketech is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact persons set out above, at 2024-05-01 22:20 CEST.

Attachments

Raketech presents a trading update for the first quarter 2024 and revised full-year 2024 guidance

SOURCE: Raketech



View the original press release on accesswire.com

© 2024 ACCESS Newswire
Gewinner im Megamarkt
Biotechnologie ist eine der bedeutendsten Zukunftstechnologien unserer Zeit. Zahlreiche Biotechnologie- und Pharmakonzerne haben sich unter anderem dem Kampf gegen Tumorerkrankungen verschrieben. Der weltweite Markt für Krebsmedikamente verzeichnet ein stetiges Wachstum. Für das Jahr 2025 wird ein Umsatz von etwa 190,3 Milliarden Euro prognostiziert, mit einer erwarteten jährlichen Wachstumsrate von 6,42% bis 2029, was zu einem geschätzten Marktvolumen von 244,1 Milliarden Euro führen würde.

Wir haben 3 aussichtsreiche Biotechnologieaktien mit Schwerpunkt Erforschung und Entwicklung von Wirkstoffen gegen Tumorerkrankungen ausfindig gemacht, die in den kommenden Monaten und Jahren erhebliches Aufwärtspotenzial versprechen und Vervielfachungspotenzial besitzen.

Fordern Sie jetzt unseren neuen kostenlosen Spezialreport an und erfahren Sie, welche 3 Biotech-Aktien durchstarten und zu Ihrem Börsenerfolg in 2025 beitragen könnten!
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.